¶¡ÏãÔ°AV

FASS News, Research

Psychedelics as therapies to reduce opioid use

May 11, 2022

¶¡ÏãÔ°AV (¶¡ÏãÔ°AV) researchers have found that recent psychedelic use was associated with 55 percent reduced odds of daily opioid use.

In the first longitudinal study of its kind, ¶¡ÏãÔ°AV researches Kora DeBeck and Kanna Hayashi have found that recent psychedelic use was associated with 55 percent reduced odds of daily opioid use. These findings add to growing knowledge and interest in the use of psychedelics—such as psilocybin, LSD, ayahuasca and others—in addition to counselling for harm reduction and treatment of substance use disorders.

DeBeck and Hayashi collaborated with researchers from the University of British Columbia and the BCCSU to follow 3800 participants over 12 years who reported on their use of opioids as well as their use of various psychedelics. The research team published their findings, , in a recent issue of the International Journal of Drug Policy.

While more studies are needed to investigate and understand the therapeutic potential of psychedelics, these findings point towards novel and holistic treatments for substance use disorders.

Facebook
Twitter
LinkedIn
Reddit
SMS
Email
Copy